TNDM - Tandem Diabetes Care, Inc.

Tandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2026 results after the financial markets close on Thursday, November 5, 2026. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its third quarter 2026 financial and operating results. A live webcast of the call will be available on Tandem Diab.

Oct 01, 2026 12:05 PM • businesswire.com

Head to Head Contrast: Solventum (NYSE:SOLV) & Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ: TNDM - Get Free Report) and Solventum (NYSE: SOLV - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations and profitability. Analyst Ratings This is a breakdown of recent

Sep 29, 2026 10:29 PM • defenseworld.net

Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets

[url="]Tandem Diabetes Care, Inc[/url]. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world'

Sep 27, 2026 11:00 PM • gurufocus.com

Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets

MILAN--(BUSINESS WIRE)---- $TNDM #T2D--The Tandem Mobi automated insulin delivery system with Control-IQ+ automated insulin delivery technology is now available in 12 international markets.

Sep 27, 2026 11:00 PM • businesswire.com

Tandem Diabetes Care (TNDM) Soars 7.7%: Is Further Upside Left in the Stock?

Tandem Diabetes Care (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Sep 17, 2026 02:35 AM • zacks.com

Is Tandem Diabetes Care Inc (TNDM) a Bargain After 4.2% Drop? GF Value Says Undervalued

On September 10, 2026, Tandem Diabetes Care Inc (TNDM) shares fell 4.2% to a current price of $18.31. The stock has experienced notable volatility, trading betw

Sep 10, 2026 04:01 PM • gurufocus.com

Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now

TNDM's expanding pump lineup and pay-as-you-go model support growth prospects, though macro and competitive pressures remain.

Sep 09, 2026 11:40 AM • zacks.com

Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionics

On Friday, William Blair initiated coverage on Tandem Diabetes Care Inc. (NASDAQ:TNDM) and Beta Bionics Inc (NASDAQ:BBNX), noting that both companies are advancing initiatives to play in faster-growing segments of the insulin pump market.

Aug 21, 2026 09:31 AM • benzinga.com

Tandem Diabetes Care Maps Growth Plan With Pharmacy Shift and Tubeless Mobi

Tandem Diabetes Care NASDAQ: TNDM highlighted its plans to expand insulin pump adoption through a shift to pharmacy distribution in the U.S., direct sales in additional international markets and upcoming product launches, including a tubeless version of its Tandem Mobi pump.

Aug 17, 2026 10:04 PM • marketbeat.com

TNDM Q2 Loss Narrower Than Expected, Revenues Miss, Stock Up

Tandem Diabetes shares jump 19.1% after a narrower-than-expected Q2 loss, as higher pump shipments and a 57% gross margin offset a slight revenue miss.

Aug 12, 2026 05:40 AM • zacks.com

Tandem Diabetes Care Q2 Earnings Call Highlights

Tandem Diabetes Care NASDAQ: TNDM reported second-quarter results that included record sales, pump shipments and gross margin for a second quarter, while management highlighted early progress in its transition to pharmacy-channel reimbursement and continued development of new insulin-delivery technologies.

Aug 07, 2026 10:04 AM • marketbeat.com

Tandem Diabetes Care, Inc. (TNDM) Q2 2026 Earnings Call Transcript

Tandem Diabetes Care, Inc. (TNDM) Q2 2026 Earnings Call Transcript

Aug 07, 2026 07:54 AM • seekingalpha.com

Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Lags Revenue Estimates

Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to a loss of $0.48 per share a year ago.

Aug 06, 2026 04:12 PM • zacks.com

Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Aug 06, 2026 04:01 PM • zacks.com

Tandem Diabetes Care Announces Second Quarter 2026 Financial Results

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) (the Company), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights Sales of $254.6 million worldwide, including $179.3 million in the United States (U.S.) Gross margin of 57%, up 460 basis points compared to second quarter 2025 Pump shipments of more than 33,000 pumps worldwide, including 22,000 pumps in t.

Aug 06, 2026 12:05 PM • businesswire.com

Does TNDM Stock Still Deserve a Place in Your Portfolio?

Tandem Diabetes Care, Inc. TNDM is well-poised to grow in the coming quarters as the rising prevalence of diabetes and increasing adoption of connected care continue to support demand for automated insulin delivery. The company's pay-as-you-go reimbursement model could lower upfront barriers for pump starts and support higher supply revenue per customer over time.

Jul 07, 2026 07:01 AM • zacks.com

Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--The t:slim X2™ insulin pump from Tandem Diabetes Care is now compatible with Abbott's FreeStyle Libre 3 Plus CGM sensor in five EU countries.

Jul 01, 2026 04:30 AM • businesswire.com

Tandem Diabetes Care to Announce Second Quarter 2026 Financial Results on August 6, 2026

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2026 results after th

Jun 30, 2026 05:00 AM • gurufocus.com

Tandem Diabetes Care to Announce Second Quarter 2026 Financial Results on August 6, 2026

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2026 results after the financial markets close on Thursday, August 6, 2026. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its second quarter 2026 financial and operating results.A live webcast of the call will be available on Tandem Diabet.

Jun 30, 2026 04:30 AM • businesswire.com

Tandem Diabetes Care, Inc. (TNDM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Tandem Diabetes Care, Inc. (TNDM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Jun 08, 2026 02:28 PM • seekingalpha.com

Tandem Diabetes initiated with an Equal Weight at Barclays

$18.00 (was $16.16)

Christopher Pasquale · Barclays

Oct 06, 2026 04:27 PM • TheFly

Tandem Diabetes price target lowered to $26 from $30 at RBC Capital

$26.00 (was $20.18)

Kendall Au · RBC Capital

Aug 07, 2026 08:28 AM • TheFly

Tandem Diabetes price target raised to $40 from $35 at Canaccord

$40.00 (was $18.79)

William Plovanic · Canaccord Genuity

Aug 07, 2026 07:39 AM • TheFly

Tandem Diabetes resumed with a Neutral at UBS

$18.00 (was $17.86)

UBS

Jul 28, 2026 07:57 AM • TheFly

Tandem Diabetes initiated with a Hold at Deutsche Bank

$15.50 (was $14.34)

Deutsche Bank

Jun 23, 2026 07:41 AM • TheFly

Tandem Diabetes upgraded to Overweight from Equal Weight at Wells Fargo

$27.00 (was $17.20)

Wells Fargo

May 31, 2026 09:11 PM • TheFly

Tandem Diabetes price target lowered to $21 from $24 at Goldman Sachs

$21.00 (was $14.54)

Goldman Sachs

May 27, 2026 07:27 AM • TheFly

Tandem Diabetes price target lowered to $55 from $56 at Barclays

$55.00 (was $15.48)

Barclays

May 11, 2026 05:49 AM • TheFly

Tandem Diabetes price target raised to $24 from $22 at Mizuho

$24.00 (was $18.47)

Anthony Petrone · Mizuho Securities

May 08, 2026 07:20 AM • TheFly

Tandem Diabetes price target raised to $45 from $36 at Rothschild & Co Redburn

$45.00 (was $20.68)

Issie Kirby · Redburn Partners

Apr 24, 2026 04:58 AM • TheFly

Tandem Diabetes price target raised to $27 from $24 at Truist

$27.00 (was $24.57)

Truist Financial

Feb 23, 2026 07:44 AM • TheFly

Tandem Diabetes upgraded to Buy from Hold at Lake Street

$50.00 (was $24.57)

Lake Street

Feb 23, 2026 07:44 AM • TheFly

Tandem Diabetes price target raised to $28 from $25 at Goldman Sachs

$28.00 (was $24.57)

David Roman · Goldman Sachs

Feb 23, 2026 06:46 AM • TheFly

Tandem Diabetes price target raised to $56 from $55 at Barclays

$56.00 (was $24.57)

Matt Miksic · Barclays

Feb 23, 2026 05:52 AM • TheFly

Tandem Diabetes price target raised to $22 from $21 at Mizuho

$22.00 (was $18.52)

Mizuho Securities

Feb 20, 2026 07:33 AM • TheFly

Tandem Diabetes price target raised to $22 from $20 at Stifel

$22.00 (was $18.52)

Stifel Nicolaus

Feb 20, 2026 07:10 AM • TheFly

Tandem Diabetes price target raised to $22 from $17 at UBS

$22.00 (was $18.52)

UBS

Feb 20, 2026 07:09 AM • TheFly

Tandem Diabetes price target raised to $21 from $14 at Piper Sandler

$21.00 (was $18.52)

Matt O'Brien · Piper Sandler

Feb 20, 2026 06:37 AM • TheFly

Tandem Diabetes price target raised to $20 from $16 at Stifel

$20.00 (was $19.11)

Stifel Nicolaus

Feb 04, 2026 08:09 AM • TheFly

Tandem Diabetes price target raised to $25 from $16 at Goldman Sachs

$25.00 (was $22.50)

David Roman · Goldman Sachs

Jan 09, 2026 05:51 AM • TheFly